IL1B and lung carcinoma: It has been reported that activation of NLRP3 inflammasome enhanced the proliferation and migration of A549 lung cancer cells [50] and that obesity-associated NLRC4 inflammasome activation/IL-1 signaling promoted breast cancer progression [51].